Osmotic implant with membrane and membrane retention means
View Patent ↗An osmotic delivery system for controlled delivery of a beneficial agent includes an implantable capsule containing a beneficial agent and an osmotic engine that swells on contact with water, thereby causing the release of the beneficial agent over time. The osmotic delivery system has a membrane material that allows a controlled amount of fluid to enter from an exterior of the capsule, while preventing the compositions within the capsule from passing out of the capsule. The osmotic delivery system is designed to meet at least the operating pressures of 1000 psi. The membrane material is cast, calendered or extruded followed by machining (i.e., die-cutting, stamping or otherwise cutting to shape) to provide a uniform nonribbed membrane material. The capsule also includes a membrane material-retaining means that is positioned at a fluid uptake end to retain the membrane material within the capsule, even under periods of high pressure.
1. A delivery system for controlled delivery of a beneficial agent, the system comprising:
an implantable capsule having a beneficial agent delivery end and a fluid uptake end, wherein the implantable capsule comprises one or a plurality of inwardly protruding ridges circumferentially arrayed near the fluid uptake end of the implantable capsule to securingly grip an outer surface of a membrane material;
a beneficial agent reservoir positioned within the implantable capsule for delivery of the beneficial agent at a predetermined delivery rate;
the membrane material received entirely within the fluid uptake end of the implantable capsule and providing a fluid permeable barrier between an interior and an exterior of the implantable capsule; and
a membrane material-retaining means for preventing the membrane material from being ejected out of the fluid uptake end of the implantable capsule;
wherein the membrane material-retaining means is positioned at the fluid uptake end of the implantable capsule and includes at least one opening for allowing passage of fluid.
2. The delivery system according to claim 1 , wherein the membrane material-retaining means comprises a retention flange positioned along an outer periphery of the fluid uptake end.
3. The delivery system according to claim 2 , wherein the retention flange and the implantable capsule are formed integrally.
4. The delivery system according to claim 2 , wherein the retention flange is a separate member attached to the implantable capsule.
5. The delivery system according to claim 4 , wherein the flange is attached to the implantable capsule by welding.
6. The delivery system according to claim 4 , wherein the flange is attached to the implantable capsule by press fit.
7. The delivery system according to claim 4 , wherein the flange is attached to the implantable capsule by screw means.
8. The delivery system according to claim 1 , wherein the membrane material-retaining means comprises a screen or a grate.
9. The delivery system according to claim 1 , wherein the membrane material-retaining means comprises a perforated disc.
10. The delivery system according to claim 1 , wherein the membrane material-retaining means has a flat, rounded, or contoured surface on at least one surface thereof.
11. The delivery system according to claim 1 , wherein the membrane material comprises a generally smooth, cylindrical shape.
12. The delivery system according to claim 1 , wherein the membrane material has a diameter between about 0.040 inch and about 0.250 inch.
13. The delivery system according to claim 1 , wherein the membrane material has a length or thickness between about 0.010 inch and about 0.350 inch.
14. The delivery system according to claim 1 , wherein the membrane material is extruded, cast, or calendered.
15. The delivery system according to claim 14 , wherein the membrane material is machined following extrusion, casting, or calendering.
16. The delivery system according to claim 1 , wherein the membrane material is machined.
17. The delivery system according to claim 16 , wherein the membrane material is die-cut.
18. The delivery system according to claim 1 , wherein the one or a plurality of inward-protruding ridges are shaped to accommodate insertion of the membrane material, while preventing withdrawal of the membrane material from the implantable capsule.
19. The delivery system according to claim 1 , further comprising an osmotic engine positioned between the beneficial agent delivery end and the membrane material.
20. The delivery system according to claim 19 , further comprising a piston positioned between the beneficial agent delivery end and the osmotic engine for transmitting a pushing force created by the osmotic engine to the beneficial agent.
21. A delivery system for controlled delivery of a beneficial agent, the system comprising:
an implantable capsule having a beneficial agent delivery end and a fluid uptake end, wherein the implantable capsule comprises one or a plurality of inwardly protruding ridges circumferentially arrayed near the fluid uptake end of the implantable capsule to securingly grip an outer surface of a membrane material;
a beneficial agent reservoir positioned within the implantable capsule for delivery of the beneficial agent at a predetermined delivery rate;
the membrane material received entirely within the fluid uptake end of the implantable capsule and providing a fluid permeable barrier between an interior and an exterior of the implantable capsule; and
a membrane material-retaining means for preventing the membrane material from being ejected out of the fluid uptake end of the implantable capsule;
wherein the membrane material-retaining means is positioned at the fluid uptake end of the implantable capsule and comprises a perforated disc.
22. A delivery system for controlled delivery of a beneficial agent, the system comprising:
an implantable capsule having a beneficial agent delivery end and a fluid uptake end, wherein the implantable capsule comprises one or a plurality of inwardly protruding ridges circumferentially arrayed near the fluid uptake end of the implantable capsule to securingly grip an outer surface of a membrane material;
a beneficial agent reservoir positioned within the implantable capsule for delivery of the beneficial agent at a predetermined delivery rate;
the membrane material received entirely within the fluid uptake end of the implantable capsule and providing a fluid permeable barrier between an interior and an exterior of the implantable capsule, the membrane material comprising a generally smooth, cylindrical shape; and
a membrane material-retaining means for preventing the membrane material from being ejected out of the fluid uptake end of the implantable capsule;
wherein the membrane material-retaining means is positioned at the fluid uptake end of the implantable capsule and includes at least one opening for allowing passage of fluid.
23. A delivery system for controlled delivery of a beneficial agent, the system comprising:
an implantable capsule having a beneficial agent delivery end and a fluid uptake end, wherein the implantable capsule comprises one or a plurality of inwardly protruding ridges circumferentially arrayed near the fluid uptake end of the implantable capsule to securingly grip an outer surface of a membrane material;
a beneficial agent reservoir positioned within the implantable capsule for delivery of the beneficial agent at a predetermined delivery rate;
the membrane material received entirely within the fluid uptake end of the implantable capsule and providing a fluid permeable barrier between an interior and an exterior of the implantable capsule, the membrane material comprising a generally smooth, cylindrical shape having a diameter between about 0.040 inch and about 0.250 inch; and
a membrane material-retaining means for preventing the membrane material from being ejected out of the fluid uptake end of the implantable capsule;
wherein the membrane material-retaining means is positioned at the fluid uptake end of the implantable capsule and includes at least one opening for allowing passage of fluid.
24. A delivery system for controlled delivery of a beneficial agent, the system comprising:
an implantable capsule having a beneficial agent delivery end and a fluid uptake end, wherein the implantable capsule comprises one or a plurality of inwardly protruding ridges circumferentially arrayed near the fluid uptake end of the implantable capsule to securingly grip an outer surface of a membrane material;
a beneficial agent reservoir positioned within the implantable capsule for delivery of the beneficial agent at a predetermined delivery rate;
the membrane material received entirely within the fluid uptake end of the implantable capsule and providing a fluid permeable barrier between an interior and an exterior of the implantable capsule, the membrane material comprising a generally smooth, cylindrical shape having a length or thickness between about 0.010 inch and about 0.350 inch; and
a membrane material-retaining means for preventing the membrane material from being ejected out of the fluid uptake end of the implantable capsule;
wherein the membrane material-retaining means is positioned at the fluid uptake end of the implantable capsule and includes at least one opening for allowing passage of fluid.
25. The delivery system according to claim 1 , wherein the membrane material-retaining means comprises a porous disc.